Novolog (pharm-up 1966) (XTAE:NVLG) Growth Rank : 5 (As of Jun. 19, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Novolog (pharm-up 1966) Growth Rank?

Novolog (pharm-up 1966) has the Growth Rank of 5.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Novolog (pharm-up 1966)'s Growth Rank

For the Medical Distribution subindustry, Novolog (pharm-up 1966)'s Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novolog (pharm-up 1966)'s Growth Rank Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Novolog (pharm-up 1966)'s Growth Rank distribution charts can be found below:

* The bar in red indicates where Novolog (pharm-up 1966)'s Growth Rank falls into.

Novolog (pharm-up 1966) Growth Rank Related Terms

Thank you for viewing the detailed overview of Novolog (pharm-up 1966)'s Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Novolog (pharm-up 1966) (XTAE:NVLG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Novolog (pharm-up 1966) Ltd (XTAE:NVLG) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Me'ayan 55, near Modi'in, PO Box 377, Modiin, ISR, 71713

Website

http://www.novolog.co.il

Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.

Novolog (pharm-up 1966) (XTAE:NVLG) Headlines

No Headlines